NuCana PLC reports results for the quarter ended in June - Earnings Summary

NuCana

16/08/2024 07:37

* NuCana PLC  NCNA.OQ  reported a quarterly adjusted loss of
£3.00​​ per share for the quarter ended in June, lower than the
same quarter last year, when the company reported EPS of
£-2.50.  The mean expectation of four analysts for the quarter
was for a loss of £1.81 per share. Wall Street expected
results to range from £-3.50 to -12 pence per share.
    * Reported revenue was zero​; analysts expected zero. 
    * NuCana PLC's reported EPS for the quarter was a loss of
$3.00​.
    * The company reported a quarterly loss of £7 million.
    * NuCana PLC shares had risen by 29.0% this quarter and
lost 55.5%
so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 18.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for NuCana PLC is
$150.00 
This summary was machine generated from LSEG data August 16 at
06:37 a.m. UTC. ​All figures in pounds unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -1.81          -3.00          Missed
 Mar. 31 2024      -2.77          -3.25          Missed
 Dec. 31 2023      -2.56          -3.50          Missed
 Sep. 30 2023      -2.51          -3.25          Missed